Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 622,385 | 659,662 | 661,377 | 568,168 | 209,447 |
| Marketable Securities | 779,023 | 732,050 | 241,314 | 282,585 | 848,495 |
| Receivables | 446,665 | 559,332 | 317,353 | 280,512 | 278,637 |
| Inventories | 263,602 | 233,987 | 169,102 | 182,815 | 251,016 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 86,880 |
| Other current assets | 346,325 | 183,376 | 323,421 | 318,771 | 256,569 |
| TOTAL | $2,458,000 | $2,368,407 | $1,712,567 | $1,632,851 | $1,931,044 |
| Non-Current Assets | |||||
| PPE Net | 1,594,754 | 1,497,383 | 1,280,385 | 1,174,396 | 1,525,225 |
| Investments And Advances | 1,126,558 | 1,133,299 | 1,657,858 | 1,468,439 | 1,265,557 |
| Intangibles | 3,299,679 | 3,629,726 | 3,901,998 | 4,106,031 | 4,443,932 |
| TOTAL | $6,020,991 | $6,260,408 | $6,840,241 | $6,748,866 | $7,234,714 |
| Total Assets | $8,478,991 | $8,628,815 | $8,552,808 | $8,381,717 | $9,165,758 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 137,408 | 298,881 | 100,457 | 99,780 | 121,471 |
| Accrued Expenses | 534,887 | 367,885 | 336,869 | 297,833 | 247,802 |
| TOTAL | $923,222 | $2,189,175 | $582,855 | $597,806 | $1,260,748 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,085,431 | 51,843 | 96,694 | 43,444 | 101,879 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 13,695 |
| aiOther Non-Current Liabilities | 273,429 | 390,404 | 79,836 | 72,309 | 54,959 |
| TOTAL | $1,721,817 | $905,345 | $820,175 | $878,035 | $1,078,609 |
| Total Liabilities | $2,645,039 | $3,094,520 | $1,403,030 | $1,475,841 | $2,339,357 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 297,253 | 297,751 | 342,437 | 344,099 | 344,027 |
| Common Shares | 149 | 147 | 173 | 173 | 173 |
| Retained earnings | 270,180 | -352,169 | -860,827 | -1,021,644 | -801,094 |
| Other shareholders' equity | 16,666 | 79,246 | 22,200 | -56,564 | -42,657 |
| TOTAL | $5,833,952 | $5,534,295 | $7,149,778 | $6,905,876 | $6,826,401 |
| Total Liabilities And Equity | $8,478,991 | $8,628,815 | $8,552,808 | $8,381,717 | $9,165,758 |